MorphoSys US Inc. drugs

1 result
  • monjuvi

    (Tafasitamab-cxix)
    MorphoSys US Inc.
    MONJUVI, in combination with lenalidomide, is indicated for treating adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not eligible for autologous stem cell transplant. Approval is based on overall response rate and may require further verification of clinical benefit.